OPKO Health Inc (FRA:XCY)
€ 1.3592 0.0658 (5.09%) Market Cap: 961.02 Mil Enterprise Value: 1.17 Bil PE Ratio: 0 PB Ratio: 0.76 GF Score: 57/100

OPKO Health Inc at Piper Sandler Healthcare Conference (Virtual) - Fireside Chat Pre-Recording Session Transcript

Nov 17, 2020 / 07:30PM GMT
Release Date Price: €3.37 (+1.95%)
Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

(technical difficulty)

analyst at Piper Sandler. Welcome to Piper Sandler's Virtual Health Care Conference. OPKO is a diversified health care company comprised of BioReference Labs, GeneDx and a fully integrated pharmaceutical business. BioReference has served an important role in the pandemic with SARS-CoV-2 PCR and antibody testing.

On the pharmaceutical side, we're awaiting Pfizer's submission of a BLA for somatrogon, a once-weekly human growth hormone. Online from OPKO is Steve Rubin, who's Executive Vice President and Administrative; Jon Cohen, Executive Chairman of BioReference; and Adam Logal, who's the CFO. Thanks for joining us, guys.

Questions & Answers

Edward Andrew Tenthoff
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

Jon, I'm going to start off and -- with you. And first and foremost, I just want to say thank you to you and everybody at BioReference for what you guys are doing during

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot